Description
Food supplement in orally soluble sachets with enteric release based on FERNANO, an innovative raw material consisting of ultramicronized microencapsulated iron bisglycinate.
The product contains 30 mg of Iron per sachet. Iron contributes to normal cognitive function, normal energy metabolism, normal red blood cell and hemoglobin formation, normal oxygen transport in the body, normal immune system function, reduction of tiredness and fatigue, and also plays a role in cell division.
Bisferr++, thanks to FERNANO's sophisticated technology, contains ultramicronized iron bisglycinate microcomplexes that allow iron to be released only in the intestinal tract, ensuring:
- high iron absorption and intestinal bioavailability, an advantage obtained by reducing the size of the microencapsulate through ULTRAMICRO technology;
- greater digestibility and excellent tolerability. This benefit is guaranteed by the microencapsulation process which, through a polymeric coating membrane, protects the iron and prevents gastrointestinal problems, eliminates metallic aftertaste and odor.

Ingredients
FERNANO (ultramicronized microencapsulated iron bisglycinate); sweeteners: mannitol, sucralose; acidifier: citric acid; flavor; anti-caking agent: silicon dioxide.

Nutritional characteristics

Average contents	per 1 sachet	NRV*
Iron	30 mg	214

*NRV=Nutrient Reference Value.

Directions for use
It is recommended to take 1 sachet per day directly into the mouth.

Warnings
Supplements should not be intended as substitutes for a varied, balanced diet and a healthy lifestyle. Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age.
Excessive consumption can have laxative effects.

Storage
Store in a cool, dry place.

Format
14 sachets of 1.5 g.
Net weight: 21 g.

Code 942142074

Bibliography:
Iron monograph. Pdr tor Nutrional supplement, First Edition. Thomson POR Staff. 2001. pp 235-240. Iron monograph. POR Nutritional Supplements. New Edition. S. Hendler, O. Jorvik. 2010. pp 247-253. Opinion of the Scientific Committee/Scientific Panel. Iron and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA Journal 2016; 14 (7): 4548 [8 pp]. M. Auerbach, H. Ballard, J. R. Trout, M. Mcllwain, A. Ackerman. H. Bahrain, et al. Intravenous Iron optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter. Open-Label. Randomized Trial. J Clin Oncol. 2004; 22 (7): 1301-7. S. Samman. Iron. Nutrition & Oletetics 2007; 64 (Suppl. 4): S126- S130. J.L. Spivak, P. Gascón, H. Ludwig. Anemia Management In Oncology And Hematology. The Oncologist 2009; 14 (Suppl. 1): 43-56 www.theoncologist.com.